What is Edumedics?
Founded in 2010 by Alice Shade and Dr. Richard Goldstein, Edumedics operates at the intersection of clinical expertise and health technology. The company provides a unique delivery model that deploys Nurse Practitioners to engage directly with individuals managing chronic health challenges. Central to this model is the proprietary Healthward technology, which facilitates point-of-care decision support. By focusing on high-risk populations that typically account for the majority of employer medical expenditures, Edumedics has achieved significant clinical improvements, including documented reductions in yearly costs and substantial enhancements in patient health outcomes. The company's transition from a university-based research project to a scalable enterprise solution highlights its robust intellectual property and operational maturity.
How much funding has Edumedics raised?
Edumedics has raised a total of $7.2M across 4 funding rounds:
Private Equity
$1.1M
Debt
$780K
Private Equity
$1.2M
Series A
$4.2M
Private Equity (2013): $1.1M, investors not publicly disclosed
Debt (2014): $780K, investors not publicly disclosed
Private Equity (2015): $1.2M, investors not publicly disclosed
Series A (2015): $4.2M featuring OCA Ventures and Lunsford Capital, LLC
Key Investors in Edumedics
OCA Ventures
OCA Ventures is a venture capital firm dedicated to assisting entrepreneurs in the development of successful companies by providing essential support and resources.
Lunsford Capital, LLC
Lunsford Capital is a private investment firm based in Louisville, Kentucky, focusing on diverse sectors including healthcare, technology, and real estate.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Edumedics?
With the successful closure of this major strategic investment, Edumedics is well-positioned to accelerate its market penetration and refine its clinical delivery infrastructure. The company's focus remains on scaling its Healthward technology to meet the needs of larger, more complex employer groups and Medicare Advantage providers. As the healthcare landscape shifts toward value-based care, Edumedics' proven ability to reduce costs while improving patient outcomes provides a competitive moat. Future strategic initiatives will likely involve expanding the clinical team and enhancing the predictive capabilities of their proprietary software to further optimize care pathways for chronic disease management.
See full Edumedics company page
